Jennison Associates’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-339,639
| Closed | -$618K | – | 617 |
|
|
2020
Q2 | $618K | Sell |
339,639
-15,127
| -4% | -$27.5K | ﹤0.01% | 572 |
|
|
2020
Q1 | $358K | Sell |
354,766
-2,589,023
| -88% | -$2.61M | ﹤0.01% | 602 |
|
|
2019
Q4 | $8.18M | Buy |
2,943,789
+2,178,665
| +285% | +$6.06M | 0.01% | 396 |
|
|
2019
Q3 | $1.17M | Buy |
765,124
+137,125
| +22% | +$209K | ﹤0.01% | 526 |
|
|
2019
Q2 | $1.31M | Buy |
+627,999
| New | +$1.31M | ﹤0.01% | 525 |
|
|
2018
Q4 | – | Sell |
-269,699
| Closed | -$2.55M | – | 639 |
|
|
2018
Q3 | $2.55M | Buy |
+269,699
| New | +$2.55M | ﹤0.01% | 509 |
|
|
2017
Q2 | – | Sell |
-140,019
| Closed | -$455K | – | 631 |
|
|
2017
Q1 | $455K | Hold |
140,019
| – | – | ﹤0.01% | 601 |
|
|
2016
Q4 | $343K | Buy |
+140,019
| New | +$343K | ﹤0.01% | 710 |
|